2m 2m 2m 2m 2m 2m 2m
QUINCE THERAP (QNCX)
NASDAQ
$29.51-$0.05 (-0.15%)
Price as of Sep 11, 2026 7:30 PM EDT- $30.1MMarket Cap
- -90.77%1-Year Change
- BiotechnologyIndustry
QUINCE THERAP (QNCX)
$29.51-$0.05 (-0.15%)
QNCX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.55 | ||
Change | +$0.59 (+2.04%) | ||
Open | $28.88 | ||
High | $30.44 | ||
Low | $28.88 | ||
Previous Close | $28.96 | ||
Volume | 11,341 | ||
30-Day Average Volume | 20,998 | ||
1-Week Change | -5.65% | ||
1-Month Change | -9.72% | ||
1-Year Change | -90.77% | ||
3-Year Change | -88.37% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.0M | ||
Total Assets | $124.0M | ||
Market Cap | $30.1M | ||
Enterprise Value | -$85.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$75.5M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$75.4M | ||
EBITDA | -$75.4M | ||
Net Working Capital | $114.9M | ||
EPS | -$12.31 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/30/2026 | ||
Earnings & Revenue